Status:
COMPLETED
Bloodstream Infection of Carbapenem-Resistant Proteus Mirabilis
Lead Sponsor:
Dokuz Eylul University
Conditions:
Proteus Mirabilis Infection
Bacteremia
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to determine the clinical characteristics, risk factors, and resistance mechanisms of patients with carbapenem-resistant P. mirabilis bacteremia.Patients with P. mirabilis growth in bl...
Detailed Description
Patients with P. mirabilis growth in blood culture who met the study criteria were divided into two groups as carbapenem susceptible and resistant according to carbapenem antibiogram results. Patients...
Eligibility Criteria
Inclusion
- Inpatients aged 18 years and older
- P. mirabilis growth in blood cultures
Exclusion
- Samples taken in emergency departments, outpatient clinics, day treatment units
- Recurrent growths of the same patient
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT06542965
Start Date
January 1 2018
End Date
January 1 2023
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dokuz Eylül University
Izmir, Turkey (Türkiye), 35400